94 related articles for article (PubMed ID: 18249559)
1. Scalable purification and characterization of the extracellular domain of human autotaxin from prokaryotic cells.
Haga A; Hashimoto K; Tanaka N; Nakamura KT; Deyashiki Y
Protein Expr Purif; 2008 May; 59(1):9-17. PubMed ID: 18249559
[TBL] [Abstract][Full Text] [Related]
2. Large scale purification and characterization of recombinant human autotaxin/lysophospholipase D from mammalian cells.
Song Y; Dilger E; Bell J; Barton WA; Fang X
BMB Rep; 2010 Aug; 43(8):541-6. PubMed ID: 20797316
[TBL] [Abstract][Full Text] [Related]
3. Expression and transcriptional regulation of the PD-Ialpha/autotaxin gene in neuroblastoma.
Kawagoe H; Stracke ML; Nakamura H; Sano K
Cancer Res; 1997 Jun; 57(12):2516-21. PubMed ID: 9192834
[TBL] [Abstract][Full Text] [Related]
4. Measurement of autotaxin/lysophospholipase D activity.
Morris AJ; Smyth SS
Methods Enzymol; 2007; 434():89-104. PubMed ID: 17954243
[TBL] [Abstract][Full Text] [Related]
5. Development of an activity-based probe for autotaxin.
Cavalli S; Houben AJ; Albers HM; van Tilburg EW; de Ru A; Aoki J; van Veelen P; Moolenaar WH; Ovaa H
Chembiochem; 2010 Nov; 11(16):2311-7. PubMed ID: 20941725
[TBL] [Abstract][Full Text] [Related]
6. Validation of an autotaxin enzyme immunoassay in human serum samples and its application to hypoalbuminemia differentiation.
Nakamura K; Igarashi K; Ide K; Ohkawa R; Okubo S; Yokota H; Masuda A; Oshima N; Takeuchi T; Nangaku M; Okudaira S; Arai H; Ikeda H; Aoki J; Yatomi Y
Clin Chim Acta; 2008 Feb; 388(1-2):51-8. PubMed ID: 17963703
[TBL] [Abstract][Full Text] [Related]
7. Autotaxin promotes the expression of matrix metalloproteinase-3 via activation of the MAPK cascade in human fibrosarcoma HT-1080 cells.
Haga A; Nagai H; Deyashiki Y
Cancer Invest; 2009 May; 27(4):384-90. PubMed ID: 19212832
[TBL] [Abstract][Full Text] [Related]
8. Identification of small-molecule inhibitors of autotaxin that inhibit melanoma cell migration and invasion.
Saunders LP; Ouellette A; Bandle R; Chang WC; Zhou H; Misra RN; De La Cruz EM; Braddock DT
Mol Cancer Ther; 2008 Oct; 7(10):3352-62. PubMed ID: 18852138
[TBL] [Abstract][Full Text] [Related]
9. Autotaxin (ATX): a multi-functional and multi-modular protein possessing enzymatic lysoPLD activity and matricellular properties.
Yuelling LM; Fuss B
Biochim Biophys Acta; 2008 Sep; 1781(9):525-30. PubMed ID: 18485925
[TBL] [Abstract][Full Text] [Related]
10. Expression, regulation and function of autotaxin in thyroid carcinomas.
Kehlen A; Englert N; Seifert A; Klonisch T; Dralle H; Langner J; Hoang-Vu C
Int J Cancer; 2004 May; 109(6):833-8. PubMed ID: 15027116
[TBL] [Abstract][Full Text] [Related]
11. Serum lysophospholipase D/autotaxin may be a new nutritional assessment marker: study on prostate cancer patients.
Nakamura K; Takeuchi T; Ohkawa R; Okubo S; Yokota H; Tozuka M; Aoki J; Arai H; Ikeda H; Ohshima N; Kitamura T; Yatomi Y
Ann Clin Biochem; 2007 Nov; 44(Pt 6):549-56. PubMed ID: 17961310
[TBL] [Abstract][Full Text] [Related]
12. Fluorogenic phospholipid substrate to detect lysophospholipase D/autotaxin activity.
Ferguson CG; Bigman CS; Richardson RD; van Meeteren LA; Moolenaar WH; Prestwich GD
Org Lett; 2006 May; 8(10):2023-6. PubMed ID: 16671772
[TBL] [Abstract][Full Text] [Related]
13. Autotaxin (NPP-2), a metastasis-enhancing motogen, is an angiogenic factor.
Nam SW; Clair T; Kim YS; McMarlin A; Schiffmann E; Liotta LA; Stracke ML
Cancer Res; 2001 Sep; 61(18):6938-44. PubMed ID: 11559573
[TBL] [Abstract][Full Text] [Related]
14. Functional invalidation of the autotaxin gene by a single amino acid mutation in mouse is lethal.
Ferry G; Giganti A; Cogé F; Bertaux F; Thiam K; Boutin JA
FEBS Lett; 2007 Jul; 581(18):3572-8. PubMed ID: 17628547
[TBL] [Abstract][Full Text] [Related]
15. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production.
Umezu-Goto M; Kishi Y; Taira A; Hama K; Dohmae N; Takio K; Yamori T; Mills GB; Inoue K; Aoki J; Arai H
J Cell Biol; 2002 Jul; 158(2):227-33. PubMed ID: 12119361
[TBL] [Abstract][Full Text] [Related]
16. Submucosal connective tissue-type mast cells contribute to the production of lysophosphatidic acid (LPA) in the gastrointestinal tract through the secretion of autotaxin (ATX)/lysophospholipase D (lysoPLD).
Mori K; Kitayama J; Aoki J; Kishi Y; Shida D; Yamashita H; Arai H; Nagawa H
Virchows Arch; 2007 Jul; 451(1):47-56. PubMed ID: 17554559
[TBL] [Abstract][Full Text] [Related]
17. Autotaxin promotes cancer invasion via the lysophosphatidic acid receptor 4: participation of the cyclic AMP/EPAC/Rac1 signaling pathway in invadopodia formation.
Harper K; Arsenault D; Boulay-Jean S; Lauzier A; Lucien F; Dubois CM
Cancer Res; 2010 Jun; 70(11):4634-43. PubMed ID: 20484039
[TBL] [Abstract][Full Text] [Related]
18. Site-directed mutations in the tumor-associated cytokine, autotaxin, eliminate nucleotide phosphodiesterase, lysophospholipase D, and motogenic activities.
Koh E; Clair T; Woodhouse EC; Schiffmann E; Liotta L; Stracke M
Cancer Res; 2003 May; 63(9):2042-5. PubMed ID: 12727817
[TBL] [Abstract][Full Text] [Related]
19. The cellular localization of autotaxin impacts on its biological functions in human thyroid carcinoma cells.
Seifert A; Klonisch T; Wulfaenger J; Haag F; Dralle H; Langner J; Hoang-Vu C; Kehlen A
Oncol Rep; 2008 Jun; 19(6):1485-91. PubMed ID: 18497954
[TBL] [Abstract][Full Text] [Related]
20. Microarray analysis identifies Autotaxin, a tumour cell motility and angiogenic factor with lysophospholipase D activity, as a specific target of cell transformation by v-Jun.
Black EJ; Clair T; Delrow J; Neiman P; Gillespie DA
Oncogene; 2004 Mar; 23(13):2357-66. PubMed ID: 14691447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
